NCT00041600Recruiting
Human Epilepsy Genetics--Neuronal Migration Disorders Study
Source: ClinicalTrials.gov · Last updated 21 Sept 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to identify genes responsible for epilepsy, brain malformations and disorders of human cognition.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3500 (estimated)
- First submitted
- 11 Jul 2002
- Start date
- Apr 1996
- Primary completion date
- Jun 2030
- Lead sponsor
- Harvard University Faculty of Medicine
- Diseases
- Epilepsy
- NCT number
- NCT00041600
What you commit to
- Study type: Observational
- Planned participants: 3500
- From Apr 1996 to the primary completion date, Jun 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- INCLUSION:
- Males and females of any age.
- Persons with a brain malformation or disorder of cognition (familial intellectual disability \[previously known as mental retardation\] or autism).
- EXCLUSION:
- Persons without a brain malformation or disorder of cognition (familial intellectual disability (previously known as mental retardation\] or autism).
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Boston Children's Hospital, Walsh Laboratory Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.